Working… Menu
Trial record 11 of 115 for:    cancer | butyrate

A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00006371
Recruitment Status : Terminated (low accrual)
First Posted : April 2, 2004
Last Update Posted : September 27, 2012
National Cancer Institute (NCI)
Janssen Pharmaceuticals
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 2001
Actual Study Completion Date : December 2001